Sort
50,496 grants matching “lung cancer”
Clinical Laboratory Core
$815,391Jennifer W Tidey · Brown University · P20 · FY2020 · GM
Artificial Lung Based on a Novel Microfluidic Technology
$815,375Anna M Galea · Infoscitex Corporation · R44 · FY2011 · HL
Perfluoroalkyl Substances (PFASs) and Liver Cancer Risk in the United States
$815,131Xuehong Zhang · Brigham And Women'S Hospital · U01 · FY2022 · CA
Molecular basis and protective efficacy of cross-neutralizing antibodies against four major respiratory viruses
$814,880Jim Boonyaratanakornkit · Fred Hutchinson Cancer Center · R01 · FY2024 · AI
Molecular basis and protective efficacy of cross-neutralizing antibodies against four major respiratory viruses
$814,880Jim Boonyaratanakornkit · Fred Hutchinson Cancer Center · R01 · FY2023 · AI
Administrative Core
$814,513Jason A Mendoza · Fred Hutchinson Cancer Center · U19 · FY2024 · MD
Germline modifiers of tumor progression and metastasis in prostate cancer
$814,460Nigel Crawford · National Human Genome Research Institute · ZIA · FY2015 · HG
Core G: Clinical Cohort and Comorbidity Research
$814,404Mari M Kitahata · University Of Washington · P30 · FY2019 · AI
Uncovering the Biology of Resistance to Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Patient-Derived Models.
$814,050Katerina Abigail Politi · Yale University · U01 · FY2019 · CA
Immune reconstitution following autologous and allogeneic stem cell transplant
$813,983Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity
$813,838William Ramses Bishai · Johns Hopkins University · R01 · FY2022 · AI
Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity
$813,838William Ramses Bishai · Johns Hopkins University · R01 · FY2024 · AI
Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity
$813,838William Ramses Bishai · Johns Hopkins University · R01 · FY2021 · AI
Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity
$813,838William Ramses Bishai · Johns Hopkins University · R01 · FY2023 · AI
Arsenic Exposure, Cardiovascular Disease and Diabetes in Native Americans
$813,665Ana Navas-Acien · Johns Hopkins University · R01 · FY2008 · HL
Longitudinal Studies of HIV-Associated Lung Infections and Complications
$813,438Kristina Anne Crothers · Yale University · R01 · FY2007 · HL
Methods for Epidemiology Studies
$813,306Paul Albert · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA
Novel Targets for Vaccine Therapy
$813,239Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal
$813,237Thomas Lad · Hektoen Institute For Medical Research · UG1 · FY2023 · CA
Epigenetic Therapy for Thoracic Malignancies
$813,216David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2019 · CA
Mitigating Hematologic Adverse Events in Patients with Myeloid Malignancies: A Novel Causal Artificial Intelligence Approach
$813,042Kun-Hsing Yu · Harvard Medical School · R01 · FY2024 · HL
Clinical Cancer Cytogenetics
$812,889Diane C Arthur · Division Of Basic Sciences - Nci · ZID · FY2013 · CA
SWOG Biospecimen Bank
$812,707Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · U24 · FY2020 · CA
Cellular Basis Of Action Of Gastrointestinal Peptides/Growth factors
$812,682Robert Jensen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
SARS-CoV-2 Surveillance Studies and Genome Sequencing in Rural New England
$812,582Michael L Whitfield · Dartmouth College · P20 · FY2021 · GM